HR Strategy & Retained Support

Back to all news & resources >

Xerion Healthcare is a Biotechnology business founded in 2015 and is a spin out from Oxford University following 8 years of research. Based and funded in the UK to develop and commercialise ‘Oxilia’ treatment, they are working hard to transform radiotherapy for cancer treatment using pioneering nanomedicine technology. We had the right HR expertise they needed to support their people.

Related Content

Why HR Can Make or Break Your Series B Funding Round

23rd April 2026Articles

Series B funding requires more than growth. Discover how HR, compliance and people strategy impact investor confidence and business scalability.

Learn more

Salary Benchmarking: Making Confident Pay Decisions in Uncertain Times

15th April 2026Articles

Salary benchmarking helps businesses make fair, informed pay decisions. Discover why it matters, how often to review it, and how to manage pay conversations with confidence.

Learn more

Preventing Workplace Stress Before It Escalates

22nd March 2026Articles

Preventing workplace stress starts with early action. Learn how organisations can spot warning signs, support managers and stop stress escalating in the workplace.

Learn more

Managing Annual Leave and Bank Holidays: A Common SME Challenge

16th March 2026Articles

Managing annual leave and bank holidays can be challenging for SMEs. Discover practical tips for balancing employee requests with operational needs.

Learn more

Employee engagement isn’t about motivation, it’s about trust

18th February 2026Articles

Blended learning often fails not because of poor content, but because it doesn’t change behaviour. This article explores why leadership capability, confidence and judgement matter more than completion rates.

Learn more

Blended learning fails when training is treated as content

12th February 2026Articles

Blended learning often fails not because of poor content, but because it doesn’t change behaviour. This article explores why leadership capability, confidence and judgement matter more than completion rates.

Learn more